Kiran Mazumdar Shaw

Chairperson, Biocon Group

Chairperson, Biocon Group

Read Less

Stories by the author

• AI-biotech sovereignty will define India’s future

  
  19 Feb 2026 11:24 PM IST
• Biotech it to the market: India’s Bioeconomy can reach $1.2 trillion by 2047 but only with bold capital-market reforms

  
  26 Nov 2025 10:42 PM IST
• From pharmacy to innovation hub: Why India needs a regulatory revolution in biotech

  
  18 Aug 2025 11:32 PM IST
• India: The unsung hero of global health security in a world of rising costs

  
  26 Feb 2025 11:14 PM IST
• View: Budget 2025, a much-needed shot of growth hormones

  
  02 Feb 2025 12:41 AM IST
• How is India transforming the global biopharma landscape?

  
  30 Dec 2024 11:00 PM IST
• CDSCO waives local trials for drugs approved in major markets

  
  18 Aug 2024 10:42 PM IST
• Blueprint for developed India, inclusive growth

  
  24 Jul 2024 12:58 AM IST
• A strong push for India's journey towards genuine universal healthcare, manufacturing, R&D: Kiran Mazumdar-Shaw

  
  02 Feb 2024 01:01 AM IST
• View: For Globalisation 4.0, the world needs digital and distributed supply chains that are agile, resilient and affordable

  
  6 mins read17 Jul 2022
• View: Covid has been an inflection point for India to emerge as a global life sciences leader

  
  6 mins read3 Apr 2022
• View: How Department of Biotechnology coordinated India's Covid-19 fight

  
  6 mins read11 Jun 2021
• View: How the Bengaluru coalition plans to beat Covid

  
  6 mins read4 Jun 2021
• A combo of lockdowns and vaccination is the only way to protect us from this viral onslaught, writes Kiran Mazumdar Shaw

  
  6 mins read3 May 2021